We are thrilled to announce the latest addition to our esteemed advisory board, Dr. Aditi Hazra, whose wealth of knowledge and extensive experience will play a pivotal role in advancing our mission of global breast cancer prevention. – UE LifeSciences
UE LifeSciences shared on LinkedIn:
“We are thrilled to announce the latest addition to our esteemed advisory board, Dr. Aditi Hazra, whose wealth of knowledge and extensive experience will play a pivotal role in advancing our mission of global breast cancer prevention. With a background deeply rooted in cancer biology, Dr. Hazra has embarked on an inspiring journey, dedicating her expertise to promoting equity in breast cancer prevention, conducting groundbreaking research across diverse populations, and imparting her wisdom through teaching. Her impressive academic journey includes a Ph.D. from The University of Texas at Austin, MD Anderson Cancer Center, a post-doctoral fellowship at the Harvard T.H. Chan School of Public Health Program in Molecular and Genetic Epidemiology, and certifications in leadership from Harvard Business School and community cancer genetics from the City of Hope. Currently holding the position of Assistant Professor of Medicine at HMX – Harvard Medical School, Brigham and Women’s Hospital, and the Veterans Affairs (VA) Boston, Dr. Hazra brings a wealth of insights and passion to our advisory board, fortifying our commitment to making a global impact on breast cancer prevention.
Dr. Hazra’s presence on our advisory board underscores our dedication to fostering innovation and leveraging the latest advancements in the fight against breast cancer. Her diverse expertise, from bench research to epidemiology, and her commitment to promoting equity will undoubtedly guide our technology’s development and implementation on a global scale. With Dr. Aditi Hazra on board, we are confident that our mission to revolutionize breast cancer prevention will gain unprecedented momentum, ultimately making a positive and lasting impact on countless lives worldwide.”
Source: UE LifeSciences/LinkedIn